Based in Houston, Texas, Nissan Chemical America Corporation is a division of Nissan Chemical Corporation founded in Japan in 1887. A forerunner in chemical innovations for more than 130 years, Nissan Chemical has been perfecting nanoparticle technology since 1951, making it one of the first companies in the world to produce highly surface-modified colloidal particles for industrial applications.
Home / Two-Well Treatment · Woodford Formation nanoActiv® HnP powered by Messer
Two-Well Treatment · Woodford Formation nanoActiv® HnP powered by Messer
February 14, 2020
Well A recovers crude production
Well B surpasses initial production
Arkoma Well A is a horizontal well drilled in June 2017 in Oklahoma with a vertical depth (TVD) of 6,500 feet and lateral length of 6,000 feet.
Prior to treatment, the well was producing 1,276 MCFD and 6 BOPD
On April 25, 2019 Arkoma Well A was treated using a nanoActiv® HnP treatment with ~7,000 gallons of nanoActiv® blend pushed by 1,600 MSCF of N₂ over approximately 55 hours.
Within 30 minutes of beginning the treatment, the pressure of the offset well began to increase, indicating the two wells were communicating. The offset well was shut-in for the remainder of the treatment. Once the treatment was complete, both wells were shut-in for more than 48 hours and reopened.
The decline curve flattened out, adding an incremental ~10,000 MCF to the production. Prior to treatment, the 30-day rolling daily decline of the two wells was .063% daily or 23% annualized. 4-months post-treatment, the 30-day rolling daily decline rate improved to .031%.
Arkoma Well B is an offset well to Arkoma Well A, located on the same pad site.
Prior to treatment, the well was producing 1,517 MCFD and 8 BOPD.
On August 26, 2019 Arkoma Well B, the offset to Arkoma Well A, was treated with ~14,000 gallons of nanoActiv® blend and 10,000 MSCF of N₂. The treatment was injected into Well A again.
Because of the communication between Wells A and B, to treat Well B, the injection had to be in Well A again.
Both wells were then shut in for a minimum of 72 hours.
Treatment #2 added an incremental 122,000 MCF to production in 180 days.